Martin Freed
Direttore/Membro del Consiglio presso SOLID BIOSCIENCES INC.
Patrimonio netto: 30 607 $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Adam Koppel | M | 54 | 7 anni | |
| Ilan Ganot | M | 50 | 11 anni | |
| Raj Shah | M | 46 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 7 anni |
| TY Howton | M | 52 | 2 anni | |
| Alexander Cumbo | M | 53 | 2 anni | |
| Clare Khan | M | 72 | 3 anni | |
| Ian Smith | M | 58 | 4 anni | |
| Annie Ganot | F | - | 11 anni | |
| Georgia Keresty | M | 62 | 3 anni | |
| Lynne Sullivan | F | 58 | 9 anni | |
| Sukumar Nagendran | M | 58 | 6 anni | |
| Sharon Cload | M | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | 16 anni |
| Adam Stone | M | 44 | 9 anni | |
| Thomas Haagen | M | 58 | 3 anni | |
| Alison Kessler | F | - | 4 anni | |
| Michael Inbar | M | - | 3 anni | |
| Kevin Tan | M | 46 | 1 anni | |
| Jamie Haney | F | - | 3 anni | |
| Ulrich Christian Otte | M | - | 3 anni | |
| Allison Bogosian | F | - | 3 anni | |
| Jessie Hanrahan | M | 47 | 2 anni | |
| Paul Herzich | M | 46 | 2 anni | |
| Shuli Kulak | M | - | - | |
| Gabriel Brooks | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Glenn Batchelder | M | 63 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Linda Higgins | M | 62 |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | - |
| Douglas Fambrough | M | 55 | 14 anni | |
| Joel Schneider | M | 39 | 8 anni | |
| Matthew Bennett Arnold | M | 55 | 8 anni | |
| Robert Morales | M | 57 | 7 anni | |
| Richard Batycky | M | 56 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 5 anni |
| Gilad D. Hayeem | M | 57 | 5 anni | |
| Mark Iwicki | M | 57 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| J. Buchi | M | 69 | 3 anni | |
| Stephen DiPalma | M | 66 | 2 anni | |
| Andrea Franz | F | 62 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Kristen K. Sheppard | F | - | 1 anni | |
| Dennis Langer | M | 73 | 12 anni | |
| Andrey Zarur | M | 54 | 7 anni | |
| Michael Nazak | M | 66 |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | - |
| Lynette Herscha | F | 52 | - | |
| Mark Stutman | M | - |
University of Delaware
| 6 anni |
| David H. Smith | M | - |
University of Delaware
| 6 anni |
| Lee Michael Ahlstrom | M | 56 |
University of Delaware
| 6 anni |
| Cynthia Smith | F | 55 | 3 anni | |
| Peter Kolchinsky | M | 47 | 6 anni | |
| Cheri D. Mitchell | F | - |
University of Delaware
| 6 anni |
| Jennifer Ziolkowski | F | 50 | 4 anni | |
| Bill Lundberg | M | 60 |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | 2 anni |
| Anna Protopapas | F | 59 | 2 anni | |
| Patrick M. Gray | M | 75 | 2 anni | |
| Stephen Hoffman | M | 70 | 14 anni | |
| Marc Kozin | M | 62 | 2 anni | |
| Josiah Craver | M | - | 3 anni | |
| John Mendlein | M | 64 |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | 3 anni |
| Donald Hayden | M | 68 | 10 anni | |
| David Michael Madden | M | 61 | 10 anni | |
| Caitlin Lowie | F | - | 1 anni | |
| Stephen Doberstein | M | 65 | 1 anni | |
| Bruce Peacock | M | 72 | 4 anni | |
| Ling Zeng | F | 55 | 2 anni | |
| Brian Halak | M | 52 | 9 anni | |
| Paul J. Miller | M | - |
University of Delaware
| 6 anni |
| Erin Brennan | M | 53 | 1 anni | |
| Tammy Reilly | F | 61 |
University of Delaware
| 7 anni |
| Bill Hassiepen | M | - |
University of Delaware
| 9 anni |
| Ashish Diwanji | M | - |
University of Delaware
| 5 anni |
| John Green | M | 43 | 6 anni | |
| Mark McDonough | M | - |
University of Delaware
| 4 anni |
| Stephanie McCormick | F | - |
University of Delaware
| 4 anni |
| Charles L. Robinson | M | - |
University of Delaware
| 4 anni |
| Patrick Casey | M | - |
University of Delaware
| 1 anni |
| John Kane | M | 55 |
University of Delaware
| 5 anni |
| Paul H. Schaffer | M | - |
University of Delaware
| 4 anni |
| Mamoru Tsuru | M | 66 |
University of Delaware
| 3 anni |
| Michael McGurk | M | - |
University of Delaware
| 4 anni |
| Simon Godwin | M | - |
University of Delaware
| 5 anni |
| Craig Stuart Hetherington | M | - |
University of Delaware
| 4 anni |
| Wayne Everett Boenig | M | - |
University of Delaware
| 4 anni |
| Guru Parulkar | M | - |
University of Delaware
| 3 anni |
| Bruce Robertson | M | 61 |
University of Delaware
| 4 anni |
| James G. Reindl | M | 65 |
University of Delaware
| 4 anni |
| Stewart John Hen | M | 57 |
University of Delaware
| 4 anni |
| Anthony Mark Petrucci | M | - |
University of Delaware
| 4 anni |
| Doug Kugler | M | 63 |
University of Delaware
| 4 anni |
| Jonathan Frederic Kolle | M | - |
University of Delaware
| 4 anni |
| Christine Frampton Williams | F | 59 |
University of Delaware
| 4 anni |
| Timothy C. Connor | M | - |
University of Delaware
| 4 anni |
| Nat C. Brinn | M | - |
University of Delaware
| 4 anni |
| Thomas Montgomery | M | 61 |
University of Delaware
| 4 anni |
| Steven R. Mast | M | - |
University of Delaware
| 4 anni |
| Barry Allen Schwartz | M | - |
University of Delaware
| 4 anni |
| Jennifer L. Fullmer | F | - |
University of Delaware
| 4 anni |
| Jack Baldwin | M | - |
University of Delaware
| 4 anni |
| Greg Scheu | M | 61 |
University of Delaware
| 4 anni |
| Anne Ullman | F | - |
University of Delaware
| 4 anni |
| Mark Shekletski | M | - |
University of Delaware
| 4 anni |
| Alan Shepard | M | - |
University of Delaware
| 4 anni |
| Jeffrey S. Hughes | M | 62 |
University of Delaware
| 4 anni |
| Doug Hopkins | M | - |
University of Delaware
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Martin Freed
- Contatti personali
